BIOMAT Database Logo BIOMAT Database Logo

Epstein-Barr virus-transformed oligoclonal B cell lines producing a cytotoxic human autoantibody. 1991

B K Weber, and I A al-Muzairai, and D A Power
Department of Medicine and Therapeutics, Aberdeen Royal Infirmary, Foresterhill, Scotland.

UI MeSH Term Description Entries
D002143 Callitrichinae A subfamily in the family CEBIDAE that consists of four genera: CALLITHRIX (marmosets), CALLIMICO (Goeldi's monkey), LEONTOPITHECUS (lion tamarins), and SAGUINUS (long-tusked tamarins). The members of this family inhabit the tropical forests of South and Central America. Cebuella,Genus Mico,Leontocebus,Mico Genus,Callithricidae,Callitrichidae,Cebuellas,Genus, Mico,Mico, Genus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

B K Weber, and I A al-Muzairai, and D A Power
Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
September 1982, The Journal of experimental medicine,
B K Weber, and I A al-Muzairai, and D A Power
Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
August 1981, International journal of cancer,
B K Weber, and I A al-Muzairai, and D A Power
Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines.
November 2020, Biomedical reports,
B K Weber, and I A al-Muzairai, and D A Power
Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report.
January 1989, Archivum immunologiae et therapiae experimentalis,
B K Weber, and I A al-Muzairai, and D A Power
In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
November 2003, DNA and cell biology,
B K Weber, and I A al-Muzairai, and D A Power
Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines.
September 1978, Journal of virology,
B K Weber, and I A al-Muzairai, and D A Power
Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
November 1982, Proceedings of the National Academy of Sciences of the United States of America,
B K Weber, and I A al-Muzairai, and D A Power
[Production of human monoclonal antibodies by Epstein-Barr virus-transformed cell lines].
October 1984, Harefuah,
B K Weber, and I A al-Muzairai, and D A Power
Erratum: Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines.
January 2021, Biomedical reports,
B K Weber, and I A al-Muzairai, and D A Power
Anti-bacterial antibodies in Epstein-Barr virus (EBV)-transformed oligoclonal B-cell lines established from normal persons and autoimmune disease patients.
October 1994, Letters in applied microbiology,
Copied contents to your clipboard!